Collection
The contribution of pannexin-1, connexins and CALHM ATP-release channels to purinergic signalling
In this issue, we will provide an up-to-date account of all aspects of the basic properties and functions of the pannexin-1, connexins and CALHM ATP-release channels and how they might be targeted therapeutically. It will include authoritative state-of-the-art articles from: Brant Isakson (Charlottesville), Nathalie Rouach (Paris), Eliseo Eugenin (Galveston), Silvia Penuela (London), Pablo Saez
(Hamburg), Juan C. Sáez (Santiago), Nick Dale (Warwick).
Editors
-
Charles Kennedy, PhD, University of Strathclyde, UK
Charles obtained a BSc (Hons) in pharmacology from Aberdeen University, then did a PhD with Geoff Burnstock at UCL, which led to the identification of the P2X and P2Y purinergic receptor subtypes. After post-doc positions in the USA and Cambridge University, he became a lecturer at Strathclyde University, where he is now an honorary reader. He chairs the IUPHAR P2X receptor nomenclature subcommittee and is a member of the P2Y subcommittee. He is also the editor-in-chief of Purinergic Signalling.
-
Nicholas Dale, PhD, University of Warwick, Coventry, UK
University of Warwick, Coventry, UK
Articles (8 in this collection)
-
-
-
-
-
-
Pannexin 1 as a driver of inflammation and ischemia–reperfusion injury
Authors (first, second and last of 6)
-
-
